Australian Medicinal Cannabis: Legal Framework and Business Opportunities
Since late 2016, Australia has legalized the cultivation, production, and manufacture of medicinal cannabis, necessitating licensing and permits. Obtaining an Office of Drug Control (ODC) license and Therapeutic Goods Administration (TGA) approvals for Good Manufacturing Practice (GMP) are prerequisites. BioGreen leads the way, assisting industries in securing ODC licenses through our ODC consultants and offering international expertise in medicinal cannabis cultivation, facility design, processing, and GMP training. We support businesses throughout their journey, from seed to final packaging and exportation.

Exporting Medicinal Cannabis from Australia
While the federal government expressed its intention to enable medicinal cannabis exports in 2018, a regulatory framework supporting this is yet to materialize. Regulations, particularly the Narcotic Drugs Regulation 2016, remain unchanged.

BioGreen’s Comprehensive Services
Our team of architects, engineers, and scientists is equipped to provide comprehensive solutions for your medicinal cannabis business. We offer process designs, optimal layouts, and regulatory approvals for both ODC and TGA licenses. Our PharmOut cannabis consultants specialize in guiding clients through the entire production cycle, from ODC applications to facility architecture, cultivation, processing, and wholesale distribution. With a proven track record of success, we confidently assist clients through the licensing process.

Obtaining a Cultivation Licence for Medicinal Cannabis in Australia
The main focus of the Australian ODC licence application is an assessment of the control over the crop, as well as people. This is to ensure that no vulnerable communities are at risk and that no unauthorised people are able to access the plants.

Australian Medicinal Cannabis Manufacturing Landscape
Since October 2016, the ODC has been processing license applications for medicinal cannabis cultivation, production, and manufacturing. Australia’s rigorous regulatory environment, built on its established opioid industry, ensures cannabis access is strictly for medical purposes.

Cultivation License Requirements
The ODC licensing process emphasizes robust control over both the crop and personnel to protect vulnerable communities and prevent unauthorized access.

Manufacturing Licenses
FDF and API licenses are required for the manufacture of medicinal cannabis in its final dosage form.

Project Management and Facility Design
BioGreen offers GMP project management services and expertise in designing pharmaceutical, medical device, and complementary medicine facilities. We conduct independent design, ODC, and GMP reviews to ensure compliance.

Regulatory Affairs and Quality Management
We provide regulatory affairs consulting to navigate Australian market regulations and offer QMS compliance services tailored to medicinal cannabis manufacturers.

Quality Control
BioGreen provides a diverse selection of services and products tailored to ensure compliance with Quality Management Systems (QMS) for producers of medical cannabis.

Online Service
For pharmaceutical and veterinary medicine production challenges, BioGreen offers convenient online services.